CL2020003238A1 - New fish virus - Google Patents
New fish virusInfo
- Publication number
- CL2020003238A1 CL2020003238A1 CL2020003238A CL2020003238A CL2020003238A1 CL 2020003238 A1 CL2020003238 A1 CL 2020003238A1 CL 2020003238 A CL2020003238 A CL 2020003238A CL 2020003238 A CL2020003238 A CL 2020003238A CL 2020003238 A1 CL2020003238 A1 CL 2020003238A1
- Authority
- CL
- Chile
- Prior art keywords
- new fish
- fish virus
- seq
- nucleic acid
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Marine Sciences & Fisheries (AREA)
- Birds (AREA)
- Insects & Arthropods (AREA)
- Food Science & Technology (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La invención se refiere a un nuevo virus de los peces, un ácido nucleico aislado que tiene una secuencia seleccionada del grupo que consiste en SEQ ID NO: 2 y 3, siendo las secuencias complementarias a SEQ ID NO: 2 y 3, y variantes de las mismas siendo idénticas al menos en un 70%. La invención también se refiere a un método para la detección del ácido nucleico, cebadores, sondas, un vector y una célula huésped, una vacuna de ADN, una proteína recombinante, una vacuna recombinante, un anticuerpo y un kit de diagnóstico.The invention relates to a new fish virus, an isolated nucleic acid having a sequence selected from the group consisting of SEQ ID NO: 2 and 3, the sequences being complementary to SEQ ID NO: 2 and 3, and variants of the same being identical in at least 70%. The invention also relates to a method for the detection of nucleic acid, primers, probes, a vector and a host cell, a DNA vaccine, a recombinant protein, a recombinant vaccine, an antibody and a diagnostic kit.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20180836A NO344698B1 (en) | 2018-06-15 | 2018-06-15 | Novel fish virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2020003238A1 true CL2020003238A1 (en) | 2021-06-11 |
Family
ID=67211790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2020003238A CL2020003238A1 (en) | 2018-06-15 | 2020-12-14 | New fish virus |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3807403A1 (en) |
| CA (1) | CA3103433A1 (en) |
| CL (1) | CL2020003238A1 (en) |
| NO (1) | NO344698B1 (en) |
| WO (1) | WO2019240596A1 (en) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60239753D1 (en) * | 2001-10-19 | 2011-05-26 | Intervet Int Bv | VACCINATE AGAINST INFECTIOUS LACHSANEMIA VIRUS |
| AU2003295600A1 (en) * | 2002-11-14 | 2004-06-15 | Dharmacon, Inc. | Functional and hyperfunctional sirna |
| US9002652B1 (en) * | 2005-01-27 | 2015-04-07 | Institute For Systems Biology | Methods for identifying and using organ-specific proteins in blood |
| WO2012066481A1 (en) * | 2010-11-15 | 2012-05-24 | Pharmaq As | New ethiological agent |
| WO2016075277A1 (en) * | 2014-11-14 | 2016-05-19 | Patogen Analyse As | Novel fish virus and method for detection |
-
2018
- 2018-06-15 NO NO20180836A patent/NO344698B1/en unknown
-
2019
- 2019-06-14 CA CA3103433A patent/CA3103433A1/en active Pending
- 2019-06-14 WO PCT/NO2019/050124 patent/WO2019240596A1/en not_active Ceased
- 2019-06-14 EP EP19737262.6A patent/EP3807403A1/en not_active Withdrawn
-
2020
- 2020-12-14 CL CL2020003238A patent/CL2020003238A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO344698B1 (en) | 2020-03-09 |
| NO20180836A1 (en) | 2019-12-16 |
| EP3807403A1 (en) | 2021-04-21 |
| CA3103433A1 (en) | 2019-12-19 |
| WO2019240596A1 (en) | 2019-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021002741A1 (en) | A prevotella and francisella crispr protein 1 (cpf1) isolated from lachnospiraceae bacterium nd2006; fusion protein comprising it; nucleic acid; vector; methods for altering the genome of a cell or a double-stranded DNA molecule in vitro using such proteins (divisional de sol. 201903004) | |
| Xu et al. | Identification of a natural viral RNA motif that optimizes sensing of viral RNA by RIG-I | |
| EA201991911A1 (en) | METHODS AND COMPOSITIONS FOR TRANSFER OF GENES ON THE VASCULAR NET | |
| Wright et al. | Serological and genetic characterisation of putative new serotypes of bluetongue virus and epizootic haemorrhagic disease virus isolated from an alpaca | |
| EA201991440A1 (en) | THERMAL STABLE NUCLEASES Cas9 | |
| Kueck et al. | Vesicular stomatitis virus transcription is inhibited by TRIM69 in the interferon-induced antiviral state | |
| MX382985B (en) | NEW TILAPIA VIRUSES AND THEIR USES | |
| EA201391109A1 (en) | NUCLEIC ACID MOLECULES ENCODING NEW HERPES ANTIGENS, VACCINE INCLUDING THEM, AND METHODS OF THEIR USE | |
| BR112018075855A2 (en) | double-overlapping adeno-associated viral vector system for abc4a expression | |
| EA202092990A2 (en) | NUCLEIC ACID MOLECULE CODING THE HEPATITIS B VIRUS CORE PROTEIN AND VACCINE CONTAINING THE INDICATED MOLECULE | |
| JP2019500414A5 (en) | ||
| RU2017125526A (en) | PESTIVIRUS | |
| PE20170941A1 (en) | HERBICIDE TOLERANCE GENES AND METHODS TO USE THEM | |
| Qin et al. | A new recombinant rabies virus expressing a green fluorescent protein: a novel and fast approach to quantify virus neutralizing antibodies | |
| MX390966B (en) | Dengue vaccines | |
| DK1664100T3 (en) | Vaccine with subunit of Lawsonia intracellularis | |
| CL2020003238A1 (en) | New fish virus | |
| EA201990539A1 (en) | NEW PARAMYXOVIRUS AND ITS APPLICATION | |
| EA202091732A1 (en) | NUCLEIC ACID CONSTRUCTIONS AND VACCINES FROM LARGE AND SMALL T-ANTIGENS OF POLIOMAVIRUS OF MERCKEL CELLS AND METHODS OF THEIR APPLICATION | |
| Bougon et al. | Influenza A virus NS1 effector domain is required for PA-X mediated host shutoff | |
| EA201990955A1 (en) | DEVELOPING AAV CAPSIDES | |
| WO2016071925A3 (en) | Integration of beta-actin gene for sample quality check in hsv-1 and hsv-2 diagnostic kit | |
| AR119634A1 (en) | RNA-GUIDED NUCLEASES AND THEIR ACTIVE FRAGMENTS AND VARIANTS AND METHODS OF USE | |
| Balasubramaniam et al. | Molecular characterization of Infectious Bronchitis virus isolated from broiler chickens showing nephropathy | |
| TH178485A (en) | Set of oligonucleotides And synthetic analog DNA Genetic testing method And genetic material testing kit For the detection of pineapple mealybug wilt-associated viruses (PMWaV). |